Variables
|
Non-lasered group (B)
|
Laser treated group (A)
|
Age (years) | 23–49 (mean 39.7 (SD 7.7), median 38) | 23–43 (mean 34.5 (SD 8.9), median 36) |
Sex | All males | All males |
Duration of symptoms (weeks) | 2–3 (median 2.4) | 2–3 (median 2.5) |
No of eyes | 9 | 4 |
Time interval between first visit and institution of laser therapy | Not applicable | 1 week |
Time interval between first visit and resolution of subretinal exudation (weeks) | 4–6 (mean 4.8 (0.8), median 5) | 4–6 (mean 4.8 (1.0), median 4.5) |
Time interval between first visit and resolution of serous RD (weeks) | 12–16 (mean 13.6 (1.3), median 14) | 10–14 (mean 12.0 (1.6), median 12) |
Residual changes after resolution of the disease | Minimal RPE changes in posterior pole and inferiorly (all 9 eyes) | Minimal RPE changes in posterior pole and inferiorly (all 4 eyes) + minimal subretinal fibrosis (2 eyes) |
Visual acuity at first visit | | |
20/60–20/100 | 6 eyes (66.6%) | 3 eyes (75%) |
20/200 or worse | 3 eyes (33.3%) | 1 eye (25%) |
Visual acuity after resolution | | |
20/2–20/30 | 8 eyes (89%) | 3 eyes (75%) |
20/40 | 1 eye (11%) | 1 eye (25%) |